The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci194434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Leo Kager und 1 weiteren Autor:innen. Beteiligte Einrichtung: St. Anna Children's Hospital, Vienna, Austria. Hauptthemen laut MEDLINE: Pyrophosphatases, Mercaptopurine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Purine Nucleotides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purine nucleotides are critical for nucleic acid synthesis, signaling, and cellular metabolism. Thiopurines (TPs), including 6-mercaptopurine and 6-thioguanine, are cornerstone agents for the treatment of acute lymphoblastic leukemia (ALL). TP efficacy and cytotoxicity depend on the metabolism and intracellular activation of TPs, a process influenced by pharmacogenes such as thiopurine-S methyltransferase ( TPMT ) and NUDIX (nucleoside diphosphates linked to moiety-X) hydrolase 15 ( NUDT15 ). In this issue of the JCI , Maillard et al. identified NUDT5 as a determinant of TP pharmacology. They demonstrated that loss of NUDT5 conferred TP resistance by impairing drug activation and DNA damage responses. Metabolomics studies by Maillard and others revealed that NUDT5 may regulate the balance between the de novo purine synthesis and salvage pathways. Clinically, NUDT5 expression variants were associated with altered TP tolerance. These findings position NUDT5 as a key modulator of nucleotide metabolism and TP efficacy, with potential implications for pharmacogenomics-guided therapy optimization in ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- St. Anna Children's Hospital, Vienna, Austria.
- Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.
- St. Anna Children's Cancer Research Institute, Vienna, Austria.
- Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences, Vienna, Austria.
Zitieren
APA
Kager, L., & Boztug, K. (2025). The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. Journal of Clinical Investigation. https://doi.org/10.1172/jci194434
Vancouver
Kager L, Boztug K. The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. Journal of Clinical Investigation. 2025. doi:10.1172/jci194434
BibTeX
@article{Kager2025,
author = {Kager, Leo and Boztug, Kaan},
title = {The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci194434}
}
EUVIMED